News|Articles|March 11, 2025
Pharma Pulse 3/11/25: Strategic Trends in Pharmaceutical Manufacturing, The Power of 'Skinfluencers' & more
Author(s)Miranda Schmalfuhs
The latest news for pharma industry insiders.
Advertisement
This link in the pharma supply chain is undergoing a major transformation propelled by technological advancements, regulatory changes, and evolving market dynamics, requiring industry leaders to adopt innovative strategies in order to remain competitive.
Skin care has spawned some of social media’s biggest stars, many of whom have lucrative deals with companies to promote their products. In some cases, they are challenging dermatologists as a source of information about the care and treatment of dermatological conditions.
Three senators are calling on Health and Human Services Secretary Robert F. Kennedy Jr. to disclose what he and President Donald Trump discussed with drugmakers during closed-door conversations.
GoodRx has released a new report, The Prescription Drug Gender Divide, detailing how women shoulder a significantly greater out-of-pocket cost burden than men. The data shows that in 2024, women spent $8.8 billion – or 30% – more than men on out-of-pocket prescription costs. Combined with the common responsibilities of managing a career, family planning, and caregiving, women are left frustrated with the financial pressure required to maintain their health.
Good News! The deadline for submissions has been extended!
Do you know someone who is driving innovation across R&D, market access, or commercialization? Or maybe you deserve the recognition yourself.
Don't miss this final opportunity to honor pharma's next generation of leaders.
Submit your entry now:
Have news you want us to share in Pharma Pulse? Reach out to Editor
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
